Company Filing History:
Years Active: 2018-2019
Title: Megumi Saeda: Innovator in Biosensor Technology
Introduction
Megumi Saeda is a prominent inventor based in Kyoto, Japan. She has made significant contributions to the field of biosensor technology, particularly in the measurement of hematocrit values in blood samples. With a total of 3 patents to her name, her work has the potential to enhance medical diagnostics and patient care.
Latest Patents
One of her latest patents is a biosensor comprising an electrode for measuring hematocrit value. This innovative method involves supplying a blood sample to a biosensor that features a hematocrit electrode. The electrode is coated with an electrically conductive polymer through physical adsorption, without the use of a crosslinking agent. The method calculates the concentration of a substance based on the measured value of a first current resulting from the application of a first voltage. Additionally, it corrects the concentration using a second current value or the hematocrit value derived from the second current. Another notable patent is a biosensor that includes multiple electrodes, featuring a working electrode and a detection layer. This detection layer is immobilized on the working electrode and contains a crosslinking agent, an electrically conductive macromolecule, and an enzyme that facilitates electron transfer.
Career Highlights
Throughout her career, Megumi Saeda has worked with reputable companies such as Arkray, Inc. and Ultizyme International Ltd. Her experience in these organizations has allowed her to develop and refine her innovative ideas in biosensor technology.
Collaborations
Megumi has collaborated with notable coworkers, including Hisashi Kaneda and Koji Katsuki. Their combined expertise has contributed to the advancement of her research and inventions.
Conclusion
Megumi Saeda is a trailblazer in the field of biosensor technology, with her innovative patents paving the way for improved medical diagnostics. Her contributions are invaluable to the scientific community and have the potential to impact patient care significantly.